New blood test could replace biopsies for brain tumor patients
NCT ID NCT06104930
First seen Mar 12, 2026 · Last updated Jun 14, 2026 · Updated 16 times
Summary
This study is testing a simple blood test to monitor meningioma brain tumors after radiation therapy. Researchers will look at tiny particles in the blood to see if they can track tumor changes and predict outcomes without needing a surgical biopsy. The study involves 60 adults with confirmed meningioma who are scheduled for radiotherapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.